A
biosimilar (also known as
follow-on biologic or
subsequent entry biologic) is a
biologic medical product which is almost an identical copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's
patent expires. Reference to the innovator product is an integral component of the approval.